Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|June 21, 2011
A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRODavid M G Halpin, Tish Laing-Morton, Sarah Spedding, et al.
Respiratory Research|July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trialKlaus F Rabe, David M G Halpin, MeiLan K Han, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 12, 2025
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UKRui Cai, Alan A Martin, Yuchen Ge, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|November 9, 2019
Home or surgery based screening for chronic obstructive pulmonary disease (COPD)?D A Seamark, S Williams, S Timon, et al.
Thorax|May 17, 2024
Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional studyMarie Stolbrink, Obianuju B Ozoh, David M G Halpin, et al.
Archivos De Bronconeumologia|February 2, 2026
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
American Journal of Respiratory and Critical Care Medicine|November 4, 2020
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary DiseaseDavid M G Halpin, Gerard J Criner, Alberto Papi, et al.
ERJ Open Research|November 14, 2019
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study designSally Worsley, Neil Snowise, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2026
Defining disease stability in COPD: Evidence from Phase 3 clinical trialsDave Singh, Rianne Stacey, David M G Halpin, et al.
Respiratory Research|July 20, 2019
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1David M G Halpin, Eli O Meltzer, Wendelgard Pisternick-Ruf, et al.
Pageof 15